Development of human tumor necrosis factor-α muteins with improved therapeutic potential

BMB Reports

Volumn 42, Issue 5, 2009, Pages 260-264

  Jang, Seung Hwan ^a   Kim, Hyojin ^a   Cho, Kwang Hwi ^a   Shin, Hang Cheol ^a  

^a Soongsil University   (South Korea)

Author keywords

Acute lethal toxicity; Cytotoxicity; Muteins; Therapeutic index; Tumor necrosis factor

Indexed keywords

EID: 66649108829     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2009.42.5.260     Document Type: Article

References (29)

1. Los, M., Burek, C. J., Stroh, C., Benedyk, K., Hug, H. and Mackiewicz, A. (2003) Anticancer drugs tomorrow: apoptotic pathways as targets for drug design. Drug Discov. Today 8, 67-77.
2. Gonzalez-Guerrico, A. M., Meshki, J., Xiao, L., Benavides, F., Conti, C. J. and Kazanietz, M. G. (2005) Molecular mechanisms of protein kinase c-induced apoptosis in prostate cancer cells. J. Biochem. Mol. Biol. 38, 639-645.
3. Fiers, W. (1991) Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett. 285, 199-212.
4. Blick, M., Sherwin, S. A., Rosenblum, M. and Gutterman, J. (1987) Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res. 47, 2986-2989.
5. Creaven, P. J., Plager, J. E., Dupere, S., Huben, R. P., Takita, H., Mittelman, A. and Proefrock, A. (1987) Phase I clinical trial of recombinant human tumor necrosis factor. Cancer Chemother. Pharmacol. 20, 137-144.
6. Kimura, K., Taguchi, T., Urushizaki, I., Ohno, R., Abe, O., Furue, H., Hattori, T., Ichihashi, H., Inoguchi, K. and Majima, H. (1987) Phase I study of recombinant human tumor necrosis factor. Cancer Chemother. Pharmacol. 20, 223-229.
7. Lejeune, F. J., Kroon, B. B., Di Filippo, F., Hoekstra, H. J., Santinam, M., Lienard, D. and Eggermont, A. M. (2001) Isolated limb perfusion: the European experience. Surg. Oncol. Clin. N. Am. 10, 821-832.
8. Hundsberger, H., Verin, A., Wiesner, C., Pflüger, M., Dulebo, A., Schütt, W., Lasters, I., Männel, D. N., Wendel, A. and Lucas, R. (2008) TNF: a moonlighting protein at the interface between cancer and infection. Front Biosci. 13, 5374-5386.
9. Curnis, F., Sacchi, A., Borgna, L., Magni, F., Gasparri, A. and Corti, A. (2000) Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13). Nat. Biotechnol. 18, 1185-1190.
10. Borsi, L., Balza, E., Carnemolla, B., Sassi, F., Castellani, P., Bernt, A., Kosmehl, H., Biro, A., Siri, A., Orecchia, P., Grassi, J., Neri, D. and Zardi, L. (2003) Selective targeted delivery of TNF-α to tumor blood vessels. Blood 102, 4384-4392.
11. Corti, A. (2004) Strategies for improving the anti-neoplastic activity of TNF by tumor targeting. Methods Mol. Med. 98, 247-264.
12. Zhang, X. M., Weber, I. and Chen, M. J. (1992) Site-directed mutational analysis of human tumor necrosis factor-alpha receptor binding site and structure-functional relationship. J. Biol. Chem. 267, 24069-24075.
13. Van Ostade, X., Tavernier, J., Prangé, T. and Fiers, W. (1991) Localization of the active site of human tumour necrosis factor (hTNF) by mutational analysis. EMBO J. 10, 827-836.
14. Van Ostade, X., Tavernier, J. and Fiers, W. (1994) Structureactivity studies of human tumor necrosis factors. Protein Eng. 7, 5-22.
15. Shin, H. C. and Cho, K. H. (2005) Mutational analysis of human tumor necrosis factor-α. Biotechnol. Lett. 27, 107-112.
16. Seong, J., Maross, C. G., Hunter, N. R., Shin, H. C. and Milas, L. (1997) Potentiation of antitumor efficacy of paclitaxel by recombinant tumor necrosis factor-alpha. Anticancer Drugs 8, 80-87.
17. Shin, N. K., Lee, I., Chang, S. G. and Shin, H. C. (1998) A novel tumor necrosis factor-α mutant with significantly enhanced cytotoxicity and receptor binding affinity. Biochem. Mol. Biol. Int. 44, 1075-1082.
18. Cha, S. S., Kim, J. S., Cho, H. S., Shin, N. K., Jeong, W., Shin, H. C., Kim, Y. J., Hahn, J. H. and Oh, B. H. (1998) High resolution crystal structure of a human TNF-α mutant with low systemic toxicity. J. Biol. Chem. 273, 2153-2160.
19. Engelmann, H., Holtmann, H., Brakebusch, C., Avni, Y. S., Sarov, I., Nophar, Y., Hadas, E., Leitner, O. and Wallach, D. (1990) Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J. Biol. Chem. 265, 14497-14504.
20. Espevik, T., Brockhaus, M., Loetscher, H., Nonstad, U. and Schalaby, M. R. (1990) Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. J. Exp. Med. 171, 415-426.
21. Schalaby, M. R., Sundan, A., Loetscher, H., Brockhaus, M., Lesslauer, W. and Espevik, T. (1990) Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors. J. Exp. Med. 172, 1517-1520.
22. Suganuma, M., Kuzuhara, T., Yamaguchi, K. and Fujiki, H. (2006) Carcinogenic Role of Tumor Necrosis Factor-α Inducing Protein of Helicobacter pylori in Human Stomach. J. Biochem. Mol. Biol. 39, 1-8.
23. Tartaglia, L. A. and Goeddel, D. V. (1992) Two TNF receptors. Immunol. Today 13, 151-153.
24. Jeong, W, Shin, N. K. and Shin, H. C. (1997) Bacterial chaperones increase the production of soluble human TNF-alpha in Escherichia coli. Biotechnol. Lett. 19, 579-582.
25. Creasey, A. A., Doyle, L. V., Reynolds, M. T., Jung, T., Lin, L. S. and Vitt, C. R. (1987) Biological effects of recombinant human tumor necrosis factor and its novel muteins on tumor and normal cell lines. Cancer Res. 47, 145-149.
26. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
27. Eck, M. J. and Sprang, S. R. (1989) The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding. J. Biol. Chem. 264, 17595-17605.
28. Banner, D. W., D'Arcy, A., Janes, W., Gentz, R., Schoenfeld, H. J., Broger, C., Loetscher, H. and Lesslauer, W. (1993) Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 73, 431-445.
29. Miyazawa, S. and Jernigan, R. L. (1996) Residue-residue potentials with a favorable contact pair term and an unfavourable high packing density term, for simulation and threading. J. Mol. Biol. 256, 623-644.